Treatment of non-small cell lung cancer

被引：0
|
作者：
Reinmuth, N. [2 ]
Heigener, D. [1 ]
Reck, M. [1 ]
机构：
[1] Krankenhaus Grosshansdorf, Onkol Schwerpunkt, D-22927 Grosshansdorf, Germany
[2] Univ Klinikum Heidelberg, Thoraxklin, Heidelberg, Germany
来源：
INTERNIST | 2011年 / 52卷 / 12期
关键词：
NSCLC; Chemotherapy; Anti-EGFR substances; Biomarkers; Angiogenesis; CLASSIFICATION; CHEMOTHERAPY; THERAPY;
D O I：
10.1007/s00108-011-2925-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Within recent years, the treatment of non-small cell lung cancer has become increasingly heterogeneous and complex. New cytotoxic agents and drugs against molecular targets have been developed. Moreover, new indications for therapy such as maintenance therapy have been explored. In addition, by assessing defined molecular markers, it is possible to identify patients who may likely respond to a given treatment. This approach will continue in the future; thus, it will be possible to characterize patient into subgroups based on molecular, histological, or clinical markers. This review will summarize the current state of the art in the treatment of non-small cell lung cancer.
引用
收藏
页码：1414 / 1421
页数：8
相关论文
共 50 条
  • [41] Sintilimab for the treatment of non-small cell lung cancer
    Lin Zhang
    Weihao Lin
    Fengwei Tan
    Ning Li
    Qi Xue
    Shugeng Gao
    Yibo Gao
    Jie He
    [J]. Biomarker Research, 10
  • [42] Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer
    Blackhall, FH
    Shepherd, FA
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (05) : 1121 - +
  • [43] Necitumumab for the treatment of squamous cell non-small cell lung cancer
    Brinkmeyer, Jessica K.
    Moore, Donald C.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (01) : 37 - 41
  • [44] Non-small cell lung cancer
    Hill, Andrew
    Fisher, Patricia
    Yeomanson, Dan
    [J]. BRITISH MEDICAL JOURNAL, 2012, 345
  • [45] Non-small cell lung cancer
    Besse, B.
    Vignot, S.
    [J]. ONCOLOGIE, 2013, 15 (7-8) : 371 - 376
  • [46] Non-small cell lung cancer
    Nestle, U.
    Hoffmann, H.
    Reck, M.
    Bruns, C.
    [J]. ONKOLOGIE, 2022, 28 (12): : 1034 - 1037
  • [47] Non-small cell lung cancer
    Sause, W
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 126 - 126
  • [48] Non-Small Cell Lung Cancer
    Ettinger, David S.
    Akerley, Wallace
    Borghaei, Hossein
    Chang, Andrew C.
    Cheney, Richard T.
    Chirieac, Lucian R.
    D'Amico, Thomas A.
    Demmy, Todd L.
    Ganti, Apar Kishor P.
    Govindan, Ramaswamy
    Grannis, Frederic W., Jr.
    Horn, Leora
    Jahan, Thierry M.
    Jahanzeb, Mohammad
    Kessinger, Anne
    Komaki, Ritsuko
    Kong, Feng-Ming
    Kris, Mark G.
    Krug, Lee M.
    Lennes, Inga T.
    Loo, Billy W., Jr.
    Martins, Renato
    O'Malley, Janis
    Osarogiagbon, Raymond U.
    Otterson, Gregory A.
    Patel, Jyoti D.
    Pinder-Schenck, Mary C.
    Pisters, Katherine M.
    Reckamp, Karen
    Riely, Gregory J.
    Rohren, Eric
    Swanson, Scott J.
    Wood, Douglas E.
    Yang, Stephen C.
    Hughes, Miranda
    Gregory, Kristina M.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (10): : 1236 - 1271
  • [49] Treatment of advanced non-small cell lung cancer in the elderly
    Sequist, LV
    Fidias, P
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (03) : 289 - 297
  • [50] Adjuvant treatment for resectable non-small cell lung cancer
    Lim, Jeong Uk
    [J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (03): : 173 - 179
12345